Recursion Pharmaceuticals Cash from Financing (TTM) Analysis

Recursion Pharmaceuticals Inc (RXRX)

8.94 +0.10 (+1.13%) USD | NASDAQ | May 06, 16:00

9.02 +0.08 (+0.89%) Pre-Market: 09:21

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	140.13M
September 30, 2023	206.73M
June 30, 2023	155.30M
March 31, 2023	154.18M
December 31, 2022	154.34M
September 30, 2022	10.88M
June 30, 2022	-2.547M

Date	Value
March 31, 2022	458.49M
December 31, 2021	458.54M
September 30, 2021	464.78M
June 30, 2021	705.60M
March 31, 2021	242.27M
December 31, 2020	246.14M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-2.547M

Minimum

Jun 2022

705.60M

Maximum

Jun 2021

261.14M

Average

206.73M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks